Publication: Intravenous tranexamic acid before and after tourniquet use can reduce blood loss and blood transfusion after total knee arthroplasty
Issued Date
2016-11-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-85010908243
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.99, No.11 (2016), 1220-1225
Suggested Citation
Surin Numkanisorn, Keerati Chareancholvanich, Chaturong Pornrattanamaneewong Intravenous tranexamic acid before and after tourniquet use can reduce blood loss and blood transfusion after total knee arthroplasty. Journal of the Medical Association of Thailand. Vol.99, No.11 (2016), 1220-1225. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/41064
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Intravenous tranexamic acid before and after tourniquet use can reduce blood loss and blood transfusion after total knee arthroplasty
Other Contributor(s)
Abstract
© 2016, Medical Association of Thailand. All rights reserved. Background: Tranexamic acid (TXA) is commonly used to reduce blood loss and blood transfusion in total knee arthroplasty (TKA). However, studies regarding the efficacy of intravenous TXA given during the intra-operative period are limited. Objective: To study the efficacy of intra-operative TXA regimen on reducing blood loss and blood transfusion in TKA. Material and Method: In this retrospective comparative study, 60 patients were divided into two groups. Patients in Group 1 were given 10 mg/kg intravenous TXA 10 minutes before inflation of the tourniquet and again immediately after deflation of the tourniquet. Patients in Group 2 did not receive TXA. Blood loss, blood transfusion, and complications were compared between the two groups. Results: Study findings revealed that intra-operative TXA regimen could significantly reduce drained blood (660±117.8 ml vs. 1,141.7±157.9 ml, p<0.001), decreasing hemoglobin at 12 hours (1.8±0.3 g/dL vs. 2.5±0.5 g/dL, p<0.001) and blood transfusion (26.7% vs. 80.0%, p<0.001) with no increase in procedure-associated complications. Conclusion: Intra-operative TXA regimen has the efficacy on reducing blood loss and blood transfusion requirement in TKA without potential risk of complications.